Leading Liver Disease Researchers Present At EASL International Liver Congress™ 2021, Demonstrate Prognostic Value Of Echosens’ FibroScan-Based Agile Scores For Patients With Liver Disease
PARIS & WALTHAM, Mass.–(BUSINESS WIRE)–Echosens, a high-technology company offering the FibroScan family of products, today announces that distinguished researchers will present studies supporting the value of FibroScan at EASL’s International…